Status:

COMPLETED

Self-Management Interventions for Chronic Pain Relief With Cancer Survivors

Lead Sponsor:

University of Washington

Collaborating Sponsors:

National Institute of Nursing Research (NINR)

Conditions:

Chronic Pain

Eligibility:

All Genders

18-90 years

Phase:

NA

Brief Summary

Cancer survivors who suffer from chronic pain would benefit from a low-cost, self-management intervention they can use at home. This study will evaluate the efficacy of a recorded hypnosis interventio...

Detailed Description

The purpose of this randomized controlled trial is to evaluate if a 4-week recorded hypnosis intervention (RHI) works for reducing chronic pain in 100 adult cancer survivors who have completed active ...

Eligibility Criteria

Inclusion

  • self-reporting moderate or higher pain on average during the last week (\> 3 on a 0-10 pain intensity numeric scale)
  • self-reporting experiencing pain at least half of the days in the past 4 weeks
  • self-reporting chronic pain related to cancer or its treatment
  • completed active cancer treatment other than maintenance therapy
  • being \> 18 years of age
  • functional fluency in English
  • mentally and physically able to participate and complete surveys

Exclusion

  • • has a psychiatric condition or symptoms (i.e., diagnosis of paranoid schizophrenia or active paranoid delusional thoughts, as determined via a telephone or in-person screening assessment) that would interfere with study participation.
  • Exclusion Criteria for Optional EEG Measurement:
  • a history of seizure condition within the last year
  • a significant brain injury or skull defect
  • a history of brain cancer.

Key Trial Info

Start Date :

February 21 2019

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

August 31 2021

Estimated Enrollment :

109 Patients enrolled

Trial Details

Trial ID

NCT03867760

Start Date

February 21 2019

End Date

August 31 2021

Last Update

November 17 2022

Active Locations (2)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (2 locations)

1

University of Illinois at Chicago

Chicago, Illinois, United States, 60607

2

Seattle Cancer Care Alliance

Seattle, Washington, United States, 98109